Loading…

Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line

Resistance to radiotherapy and chemotherapy has been a major problem of conventional cancer therapies, which consequently leads to cancer relapse and cancer‐related death. It is known that cancer stem cells (CSCs) play a key role in therapy resistance and CSC‐based targeted therapies have been consi...

Full description

Saved in:
Bibliographic Details
Published in:Cell biology international 2020-12, Vol.44 (12), p.2499-2511
Main Authors: Johari, Behrooz, Rahmati, Mohammad, Nasehi, Leila, Mortazavi, Yousef, Faghfoori, Mohammad Hasan, Rezaeejam, Hamed
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683
cites cdi_FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683
container_end_page 2511
container_issue 12
container_start_page 2499
container_title Cell biology international
container_volume 44
creator Johari, Behrooz
Rahmati, Mohammad
Nasehi, Leila
Mortazavi, Yousef
Faghfoori, Mohammad Hasan
Rezaeejam, Hamed
description Resistance to radiotherapy and chemotherapy has been a major problem of conventional cancer therapies, which consequently leads to cancer relapse and cancer‐related death. It is known that cancer stem cells (CSCs) play a key role in therapy resistance and CSC‐based targeted therapies have been considered as a powerful tool for cancer treatment. In the current study, we investigated the synergistic effects of suppressing signal transducer and activator of transcription (STAT3) function by decoy ODNs on X‐irradiation (XI) and methotrexate (MTX) exposure as a combinational therapy in triple‐negative breast cancer (TNBC) MDA‐MB‐231 cells. Lipofectamine 2000® was used as a transfecting agent and the cells treated with Scramble ODNs (SCR) and decoy ODNs were subjected to irradiation with 2 Gy at single/fractionated (XI group) doses, different concentration of MTX group, and X‐irradiation‐methotrexate (XI/MTX group). Synergistic effects of STAT3 SCR and decoy ODNs on cells were investigated by cell viability (MTT), cell cycle profile, apoptosis rate, migration, and invasion assays. Statistical analysis of obtained data showed that STAT3 decoy ODNs significantly decreased the cell viability, arrested the growth at G0/G1 phase, increased apoptosis rate, and reduced migrated and invaded cells through transwell membrane, in XI, MTX, and XI/MTX exposed groups. Since STAT3 is a master transcription factor in breast cancer cells stemness, aggressiveness, TNBC's heterogeneity, and therapy resistance; therefore, inhibition of this transcription factor by decoy ODNs could increase antitumor efficiencies of XI and MTX exposure strategies. Accordingly, this method could have the potential to increase the efficiency of combination therapies.
doi_str_mv 10.1002/cbin.11456
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2437404254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2437404254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683</originalsourceid><addsrcrecordid>eNp9kc1O3TAQhS3UStBbNjyBJRagSoH4N_ESriggoXbRyzpy7AkY5doXOynNM_SlcQgrFqzmLL5zZkYHoSNSnpGypOemdf6MEC7kHjogpRJFzYT4MmspCqmU2EffUnoqywzV8gD9v_qr-1EPLngcOvxnc7Fh2IIJEw69ewgWwr_Jj6aHMDgL6QSnyUN8cGlwBkPXgRkSzuaorVtitLfnIWLzCNswPELUuwk7j7cw6DTo2dZGyBIb7Q1kEPoe987Dd_S1032Cw_e5Qvc_rzbrm-Lu9_Xt-uKuMIxxWaiKd0JbwRnlWlLWslZKUuePKm55zWktVKuEqThISZUyhElruhosFRZkzVbodMndxfA8QhqarUvzFdpDGFNDOat4yWnesELHH9CnMEafr8uUUKRSNZWZ-rFQJoaUInTNLrqtjlNDymbupZl7ad56yTBZ4BfXw_QJ2awvb38tnlcnuZDV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2459179826</pqid></control><display><type>article</type><title>Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Johari, Behrooz ; Rahmati, Mohammad ; Nasehi, Leila ; Mortazavi, Yousef ; Faghfoori, Mohammad Hasan ; Rezaeejam, Hamed</creator><creatorcontrib>Johari, Behrooz ; Rahmati, Mohammad ; Nasehi, Leila ; Mortazavi, Yousef ; Faghfoori, Mohammad Hasan ; Rezaeejam, Hamed</creatorcontrib><description>Resistance to radiotherapy and chemotherapy has been a major problem of conventional cancer therapies, which consequently leads to cancer relapse and cancer‐related death. It is known that cancer stem cells (CSCs) play a key role in therapy resistance and CSC‐based targeted therapies have been considered as a powerful tool for cancer treatment. In the current study, we investigated the synergistic effects of suppressing signal transducer and activator of transcription (STAT3) function by decoy ODNs on X‐irradiation (XI) and methotrexate (MTX) exposure as a combinational therapy in triple‐negative breast cancer (TNBC) MDA‐MB‐231 cells. Lipofectamine 2000® was used as a transfecting agent and the cells treated with Scramble ODNs (SCR) and decoy ODNs were subjected to irradiation with 2 Gy at single/fractionated (XI group) doses, different concentration of MTX group, and X‐irradiation‐methotrexate (XI/MTX group). Synergistic effects of STAT3 SCR and decoy ODNs on cells were investigated by cell viability (MTT), cell cycle profile, apoptosis rate, migration, and invasion assays. Statistical analysis of obtained data showed that STAT3 decoy ODNs significantly decreased the cell viability, arrested the growth at G0/G1 phase, increased apoptosis rate, and reduced migrated and invaded cells through transwell membrane, in XI, MTX, and XI/MTX exposed groups. Since STAT3 is a master transcription factor in breast cancer cells stemness, aggressiveness, TNBC's heterogeneity, and therapy resistance; therefore, inhibition of this transcription factor by decoy ODNs could increase antitumor efficiencies of XI and MTX exposure strategies. Accordingly, this method could have the potential to increase the efficiency of combination therapies.</description><identifier>ISSN: 1065-6995</identifier><identifier>EISSN: 1095-8355</identifier><identifier>DOI: 10.1002/cbin.11456</identifier><language>eng</language><publisher>London: Wiley Subscription Services, Inc</publisher><subject>Apoptosis ; Breast cancer ; Cancer therapies ; Cell cycle ; Cell migration ; Cell viability ; Chemotherapy ; decoy ODNs ; G1 phase ; Metastases ; Methotrexate ; Oligonucleotides ; Radiation therapy ; radiotherapy ; Stat3 protein ; STAT3 transcription factor ; Statistical analysis ; Stem cells ; Transcription factors</subject><ispartof>Cell biology international, 2020-12, Vol.44 (12), p.2499-2511</ispartof><rights>2020 International Federation for Cell Biology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683</citedby><cites>FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683</cites><orcidid>0000-0003-3440-572X ; 0000-0002-1382-2260</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Johari, Behrooz</creatorcontrib><creatorcontrib>Rahmati, Mohammad</creatorcontrib><creatorcontrib>Nasehi, Leila</creatorcontrib><creatorcontrib>Mortazavi, Yousef</creatorcontrib><creatorcontrib>Faghfoori, Mohammad Hasan</creatorcontrib><creatorcontrib>Rezaeejam, Hamed</creatorcontrib><title>Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line</title><title>Cell biology international</title><description>Resistance to radiotherapy and chemotherapy has been a major problem of conventional cancer therapies, which consequently leads to cancer relapse and cancer‐related death. It is known that cancer stem cells (CSCs) play a key role in therapy resistance and CSC‐based targeted therapies have been considered as a powerful tool for cancer treatment. In the current study, we investigated the synergistic effects of suppressing signal transducer and activator of transcription (STAT3) function by decoy ODNs on X‐irradiation (XI) and methotrexate (MTX) exposure as a combinational therapy in triple‐negative breast cancer (TNBC) MDA‐MB‐231 cells. Lipofectamine 2000® was used as a transfecting agent and the cells treated with Scramble ODNs (SCR) and decoy ODNs were subjected to irradiation with 2 Gy at single/fractionated (XI group) doses, different concentration of MTX group, and X‐irradiation‐methotrexate (XI/MTX group). Synergistic effects of STAT3 SCR and decoy ODNs on cells were investigated by cell viability (MTT), cell cycle profile, apoptosis rate, migration, and invasion assays. Statistical analysis of obtained data showed that STAT3 decoy ODNs significantly decreased the cell viability, arrested the growth at G0/G1 phase, increased apoptosis rate, and reduced migrated and invaded cells through transwell membrane, in XI, MTX, and XI/MTX exposed groups. Since STAT3 is a master transcription factor in breast cancer cells stemness, aggressiveness, TNBC's heterogeneity, and therapy resistance; therefore, inhibition of this transcription factor by decoy ODNs could increase antitumor efficiencies of XI and MTX exposure strategies. Accordingly, this method could have the potential to increase the efficiency of combination therapies.</description><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell migration</subject><subject>Cell viability</subject><subject>Chemotherapy</subject><subject>decoy ODNs</subject><subject>G1 phase</subject><subject>Metastases</subject><subject>Methotrexate</subject><subject>Oligonucleotides</subject><subject>Radiation therapy</subject><subject>radiotherapy</subject><subject>Stat3 protein</subject><subject>STAT3 transcription factor</subject><subject>Statistical analysis</subject><subject>Stem cells</subject><subject>Transcription factors</subject><issn>1065-6995</issn><issn>1095-8355</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3TAQhS3UStBbNjyBJRagSoH4N_ESriggoXbRyzpy7AkY5doXOynNM_SlcQgrFqzmLL5zZkYHoSNSnpGypOemdf6MEC7kHjogpRJFzYT4MmspCqmU2EffUnoqywzV8gD9v_qr-1EPLngcOvxnc7Fh2IIJEw69ewgWwr_Jj6aHMDgL6QSnyUN8cGlwBkPXgRkSzuaorVtitLfnIWLzCNswPELUuwk7j7cw6DTo2dZGyBIb7Q1kEPoe987Dd_S1032Cw_e5Qvc_rzbrm-Lu9_Xt-uKuMIxxWaiKd0JbwRnlWlLWslZKUuePKm55zWktVKuEqThISZUyhElruhosFRZkzVbodMndxfA8QhqarUvzFdpDGFNDOat4yWnesELHH9CnMEafr8uUUKRSNZWZ-rFQJoaUInTNLrqtjlNDymbupZl7ad56yTBZ4BfXw_QJ2awvb38tnlcnuZDV</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Johari, Behrooz</creator><creator>Rahmati, Mohammad</creator><creator>Nasehi, Leila</creator><creator>Mortazavi, Yousef</creator><creator>Faghfoori, Mohammad Hasan</creator><creator>Rezaeejam, Hamed</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3440-572X</orcidid><orcidid>https://orcid.org/0000-0002-1382-2260</orcidid></search><sort><creationdate>202012</creationdate><title>Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line</title><author>Johari, Behrooz ; Rahmati, Mohammad ; Nasehi, Leila ; Mortazavi, Yousef ; Faghfoori, Mohammad Hasan ; Rezaeejam, Hamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell migration</topic><topic>Cell viability</topic><topic>Chemotherapy</topic><topic>decoy ODNs</topic><topic>G1 phase</topic><topic>Metastases</topic><topic>Methotrexate</topic><topic>Oligonucleotides</topic><topic>Radiation therapy</topic><topic>radiotherapy</topic><topic>Stat3 protein</topic><topic>STAT3 transcription factor</topic><topic>Statistical analysis</topic><topic>Stem cells</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johari, Behrooz</creatorcontrib><creatorcontrib>Rahmati, Mohammad</creatorcontrib><creatorcontrib>Nasehi, Leila</creatorcontrib><creatorcontrib>Mortazavi, Yousef</creatorcontrib><creatorcontrib>Faghfoori, Mohammad Hasan</creatorcontrib><creatorcontrib>Rezaeejam, Hamed</creatorcontrib><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johari, Behrooz</au><au>Rahmati, Mohammad</au><au>Nasehi, Leila</au><au>Mortazavi, Yousef</au><au>Faghfoori, Mohammad Hasan</au><au>Rezaeejam, Hamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line</atitle><jtitle>Cell biology international</jtitle><date>2020-12</date><risdate>2020</risdate><volume>44</volume><issue>12</issue><spage>2499</spage><epage>2511</epage><pages>2499-2511</pages><issn>1065-6995</issn><eissn>1095-8355</eissn><abstract>Resistance to radiotherapy and chemotherapy has been a major problem of conventional cancer therapies, which consequently leads to cancer relapse and cancer‐related death. It is known that cancer stem cells (CSCs) play a key role in therapy resistance and CSC‐based targeted therapies have been considered as a powerful tool for cancer treatment. In the current study, we investigated the synergistic effects of suppressing signal transducer and activator of transcription (STAT3) function by decoy ODNs on X‐irradiation (XI) and methotrexate (MTX) exposure as a combinational therapy in triple‐negative breast cancer (TNBC) MDA‐MB‐231 cells. Lipofectamine 2000® was used as a transfecting agent and the cells treated with Scramble ODNs (SCR) and decoy ODNs were subjected to irradiation with 2 Gy at single/fractionated (XI group) doses, different concentration of MTX group, and X‐irradiation‐methotrexate (XI/MTX group). Synergistic effects of STAT3 SCR and decoy ODNs on cells were investigated by cell viability (MTT), cell cycle profile, apoptosis rate, migration, and invasion assays. Statistical analysis of obtained data showed that STAT3 decoy ODNs significantly decreased the cell viability, arrested the growth at G0/G1 phase, increased apoptosis rate, and reduced migrated and invaded cells through transwell membrane, in XI, MTX, and XI/MTX exposed groups. Since STAT3 is a master transcription factor in breast cancer cells stemness, aggressiveness, TNBC's heterogeneity, and therapy resistance; therefore, inhibition of this transcription factor by decoy ODNs could increase antitumor efficiencies of XI and MTX exposure strategies. Accordingly, this method could have the potential to increase the efficiency of combination therapies.</abstract><cop>London</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/cbin.11456</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-3440-572X</orcidid><orcidid>https://orcid.org/0000-0002-1382-2260</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1065-6995
ispartof Cell biology international, 2020-12, Vol.44 (12), p.2499-2511
issn 1065-6995
1095-8355
language eng
recordid cdi_proquest_miscellaneous_2437404254
source Wiley-Blackwell Read & Publish Collection
subjects Apoptosis
Breast cancer
Cancer therapies
Cell cycle
Cell migration
Cell viability
Chemotherapy
decoy ODNs
G1 phase
Metastases
Methotrexate
Oligonucleotides
Radiation therapy
radiotherapy
Stat3 protein
STAT3 transcription factor
Statistical analysis
Stem cells
Transcription factors
title Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A28%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20STAT3%20decoy%20oligodeoxynucleotides'%20synergistic%20effects%20on%20radiation%20and/or%20chemotherapy%20in%20metastatic%20breast%20cancer%20cell%20line&rft.jtitle=Cell%20biology%20international&rft.au=Johari,%20Behrooz&rft.date=2020-12&rft.volume=44&rft.issue=12&rft.spage=2499&rft.epage=2511&rft.pages=2499-2511&rft.issn=1065-6995&rft.eissn=1095-8355&rft_id=info:doi/10.1002/cbin.11456&rft_dat=%3Cproquest_cross%3E2437404254%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3346-974f5ad54324a623b3b661801174d4842859b95c74e66299c136dcf8ed25de683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2459179826&rft_id=info:pmid/&rfr_iscdi=true